Schedule 13D ownership disclosure
Altamira Therapeutics Ltd.
Security class unavailable · CUSIP: G0360L209
Event date: 2023-01-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-23-003463
- Form type
- SC 13D
- Filer
- Altamira Therapeutics Ltd.
- CIK
- CIK 1601936
- Filed
- Jan 18, 2023
- Reporting period
- Jan 03, 2023
- Description
- Schedule 13D beneficial ownership